SEC Form 4 · accession 0001209191-18-047737
Cardlytics, Inc. · CDLX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Thomas Evans
Officer — Chief Financial Officer
Period of report
Aug 17, 2018
Accepted (ET)
Aug 21, 2018 · 4:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001666071
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 17, 2018 | S | 1,198 | $20.66 | D | 4,161 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares sold to cover taxes due upon the settlement of certain restricted stock unit grants.